510(k) K210385

cobas Cdiff nucleic acid test for use on the cobas Liat System by Roche Molecular Systems, Inc. — Product Code OZN

K210385 is an FDA 510(k) premarket notification submitted by Roche Molecular Systems, Inc. for the device "cobas Cdiff nucleic acid test for use on the cobas Liat System". The FDA issued a decision of Substantially Equivalent on Sep 9, 2021. The device falls under product code OZN (C. Difficile Toxin Gene Amplification Assay), a Class II device regulated under 21 CFR 866.3130. Roche Molecular Systems, Inc. has 54 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Sep 9, 2021
Date Received
Feb 9, 2021
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
C. Difficile Toxin Gene Amplification Assay
Device Class
Class II
Regulation Number
866.3130
Review Panel
MI
Submission Type
510(k)

Amplification assay for the detection of c. Difficile toxin genes from stool specimens of symptomatic patients.

Need the full FDA record for Roche Molecular Systems, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K210385. Report a data issue: hello@regdatalab.com.